Home / Stocks / AMAT

Applied Materials (AMAT, Chipmaking equipment) Stock Valuation & Fair Value

Significantly overvalued

Applied Materials (AMAT, Chipmaking equipment) trades at a current P/E of 25.9, about 54% above its historical normal valuation, with a forward growth estimate of 26.2% and a PEG of 0.99. Analysts' one-year estimates have been hit 18% of the time. Priced at its historical normal P/E of 16.9 on the same blended earnings, the 2026-11-06 close of $332.72 corresponds to about $217 a share. This is a valuation reference, not a price target. The $332.72 close is the one the P/E is read at; the technical context below uses the 2026-11-06 close, $332.71.

How to read these numbers: the PEG ratio and current P/E versus normal P/E.

Current P/E
25.9
Normal P/E
16.9
PEG
0.99
Fwd growth
26.2%
Div yield
0.6%
RSI (14)
30.3
Neutral
Technical context
  • Price $332.71 at the Nov 6 close, 17.0% below the 20-day average ($400.83) and 25.2% below the 50-day ($444.84).
  • RSI (14) at 30.3.
  • 52-week range $219.45 to $722.23: the price is 53.9% below the high and 51.6% above the low.
  • At its last earnings report the options market priced a 9.2% move.

The Street vs SeerForecast

Wall Street's mean price target for AMAT is $627.54 across 37 analysts, 88.6% above the current price. The average analyst rating is Strong Buy. Our SeerForecast read of the same stock, formed without analyst targets: significantly overvalued. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating changed 2 times after 2026-06-03 and is back where it started: significantly overvalued as of 2026-11-02.

Current P/E and rating by weekCurrent P/E moved from 40.9 to 30.6 between 2026-06-03 and 2026-10-30, against a normal P/E of 16.9, with 2 rating changes over 21 recorded weeks.2026-06-03: P/E 40.9, Significantly overvalued, recalculated for the week of 2026-06-032026-06-10: P/E 40.9, Significantly overvalued, recalculated for the week of 2026-06-102026-06-12: P/E 40.9, Significantly overvalued, recalculated for the week of 2026-06-142026-06-16: P/E 40.9, Significantly overvalued, recalculated for the week of 2026-06-162026-06-18: P/E 40.9, Significantly overvalued, recalculated for the week of 2026-06-212026-07-02: P/E 57.6, Significantly overvalued, recalculated for the week of 2026-07-022026-07-06: P/E 53.4, Significantly overvalued, recalculated for the week of 2026-07-062026-07-09: P/E 53.4, Significantly overvalued, recalculated for the week of 2026-07-092026-07-10: P/E 52.8, Significantly overvalued, recalculated for the week of 2026-07-122026-07-13: P/E 52.8, Significantly overvalued, recalculated for the week of 2026-07-132026-07-14: P/E 52.8, Significantly overvalued, recalculated for the week of 2026-07-142026-07-20: P/E 46.2, Favorable on our tests, recalculated for the week of 2026-07-202026-07-22: P/E 46.2, Favorable on our tests, recalculated for the week of 2026-07-222026-07-24: P/E 46.6, Favorable on our tests, recalculated for the week of 2026-07-252026-07-27: P/E 46.6, Favorable on our tests, recalculated for the week of 2026-07-272026-07-31: P/E 43.4, Favorable on our tests, recalculated for the week of 2026-07-312026-07-31: P/E 43.9, Favorable on our tests, recorded live 2026-08-032026-08-07: P/E 45.4, Favorable on our tests, recalculated for the week of 2026-08-072026-08-07: P/E 46.4, Favorable on our tests, recorded live 2026-08-102026-08-14: P/E 44.4, Favorable on our tests, recalculated for the week of 2026-08-142026-08-14: P/E 42.1, Favorable on our tests, recorded live 2026-08-172026-08-21: P/E 41.0, Favorable on our tests, recalculated for the week of 2026-08-212026-08-21: P/E 40.6, Favorable on our tests, recorded live 2026-08-242026-08-27: P/E 40.6, Favorable on our tests, recalculated for the week of 2026-08-272026-08-28: P/E 37.9, Favorable on our tests, recalculated for the week of 2026-08-302026-08-28: P/E 37.9, Favorable on our tests, recorded live 2026-08-312026-09-04: P/E 37.1, Favorable on our tests, recalculated for the week of 2026-09-052026-09-04: P/E 37.1, Favorable on our tests, recorded live 2026-09-072026-09-11: P/E 37.1, Favorable on our tests, recalculated for the week of 2026-09-122026-09-11: P/E 37.1, Favorable on our tests, recorded live 2026-09-142026-09-18: P/E 36.0, Favorable on our tests, recalculated for the week of 2026-09-192026-09-18: P/E 36.0, Favorable on our tests, recorded live 2026-09-212026-09-25: P/E 39.0, Favorable on our tests, recalculated for the week of 2026-09-262026-09-25: P/E 39.0, Significantly overvalued, recorded live 2026-09-282026-10-02: P/E 43.2, Significantly overvalued, recorded live 2026-10-052026-10-09: P/E 43.2, Significantly overvalued, recalculated for the week of 2026-10-102026-10-09: P/E 40.4, Significantly overvalued, recorded live 2026-10-122026-10-16: P/E 32.4, Significantly overvalued, recalculated for the week of 2026-10-172026-10-16: P/E 32.4, Significantly overvalued, recorded live 2026-10-192026-10-23: P/E 29.7, Significantly overvalued, recalculated for the week of 2026-10-242026-10-23: P/E 29.7, Significantly overvalued, recorded live 2026-10-262026-10-30: P/E 30.6, Significantly overvalued, recalculated for the week of 2026-10-312026-10-30: P/E 30.6, Significantly overvalued, recorded live 2026-11-0220.040.0Jun 3Jul 10Aug 16Sep 23Oct 30Normal P/E 16.9
Favorable on our testsSignificantly overvaluedLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated are worked out from the metrics tickerseer archived that week.

Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.

WeekCurrent P/EPremium to normal P/ERating
2026-06-03P/E 40.9+142%Significantly overvalued (recalculated)
2026-07-02P/E 57.6+242%Significantly overvalued (recalculated)
2026-07-20P/E 46.2+174%Favorable on our tests (recalculated)
2026-09-28P/E 39.0+132%Significantly overvalued (across a rating rules change)
2026-10-24P/E 29.7+76%Significantly overvalued (recalculated)
2026-11-02P/E 30.6+82%Significantly overvalued ← now
Show all 43 readings
WeekCurrent P/EPremium to normal P/ERating
2026-06-03P/E 40.9+142%Significantly overvalued (recalculated)
2026-06-10P/E 40.9+143%Significantly overvalued (recalculated)
2026-06-14P/E 40.9+143%Significantly overvalued (recalculated)
2026-06-16P/E 40.9+143%Significantly overvalued (recalculated)
2026-06-21P/E 40.9+143%Significantly overvalued (recalculated)
2026-07-02P/E 57.6+242%Significantly overvalued (recalculated)
2026-07-06P/E 53.4+217%Significantly overvalued (recalculated)
2026-07-09P/E 53.4+217%Significantly overvalued (recalculated)
2026-07-12P/E 52.8+214%Significantly overvalued (recalculated)
2026-07-13P/E 52.8+214%Significantly overvalued (recalculated)
2026-07-14P/E 52.8+214%Significantly overvalued (recalculated)
2026-07-20P/E 46.2+174%Favorable on our tests (recalculated)
2026-07-22P/E 46.2+174%Favorable on our tests (recalculated)
2026-07-25P/E 46.6+176%Favorable on our tests (recalculated)
2026-07-27P/E 46.6+176%Favorable on our tests (recalculated)
2026-07-31P/E 43.4+158%Favorable on our tests (recalculated)
2026-08-03P/E 43.9+160%Favorable on our tests
2026-08-07P/E 45.4+170%Favorable on our tests (recalculated)
2026-08-10P/E 46.4+175%Favorable on our tests
2026-08-14P/E 44.4+164%Favorable on our tests (recalculated)
2026-08-17P/E 42.1+150%Favorable on our tests
2026-08-21P/E 41.0+143%Favorable on our tests (recalculated)
2026-08-24P/E 40.6+141%Favorable on our tests
2026-08-27P/E 40.6+141%Favorable on our tests (recalculated)
2026-08-30P/E 37.9+125%Favorable on our tests (recalculated)
2026-08-31P/E 37.9+125%Favorable on our tests
2026-09-05P/E 37.1+120%Favorable on our tests (recalculated)
2026-09-07P/E 37.1+120%Favorable on our tests
2026-09-12P/E 37.1+120%Favorable on our tests (recalculated)
2026-09-14P/E 37.1+120%Favorable on our tests
2026-09-19P/E 36.0+113%Favorable on our tests (recalculated)
2026-09-21P/E 36.0+113%Favorable on our tests
2026-09-26P/E 39.0+132%Favorable on our tests (recalculated)
2026-09-28P/E 39.0+132%Significantly overvalued (across a rating rules change)
2026-10-05P/E 43.2+156%Significantly overvalued
2026-10-10P/E 43.2+156%Significantly overvalued (recalculated)
2026-10-12P/E 40.4+140%Significantly overvalued
2026-10-17P/E 32.4+92%Significantly overvalued (recalculated)
2026-10-19P/E 32.4+92%Significantly overvalued
2026-10-24P/E 29.7+76%Significantly overvalued (recalculated)
2026-10-26P/E 29.7+76%Significantly overvalued
2026-10-31P/E 30.6+82%Significantly overvalued (recalculated)
2026-11-02P/E 30.6+82%Significantly overvalued ← now

Earnings moves: AMAT moved more than the options market implied in 0 of 1 recent tracked reports.

Frequently asked questions

Is Applied Materials stock overvalued?

At a current P/E of 25.9 versus its historical normal P/E of 16.9, Applied Materials trades about 54% above its typical valuation, with a PEG of 0.99 on 26.2% forward growth. tickerseer currently rates it significantly overvalued.

What is Applied Materials's fair value and PEG?

Applied Materials trades at a current P/E of 25.9 against a historical normal P/E of 16.9, a PEG of 0.99, and a forward growth estimate of 26.2%. Priced at its historical normal P/E of 16.9 on the same blended earnings, the 2026-11-06 close of $332.72 corresponds to about $217 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of Applied Materials changed?

tickerseer's rating changed 2 times after 2026-06-03 and is back where it started: significantly overvalued as of 2026-11-02.

What is the analyst price target for Applied Materials?

The mean Wall Street price target for Applied Materials is $627.54 across 37 analysts, 88.6% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Chipmaking equipment. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and an AI research note where we have one. Options setups and metric history are part of the paid plans.

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.